BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 753613)

  • 21. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differences in serotonin and dopamine metabolism in psychopathy and sluggish schizophrenia].
    Zabrodin GD; Turova ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(11):1673-7. PubMed ID: 1015096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enzymologic and chemico-clinical findings in schizophrenic syndromes].
    Rizzoli AA; Galzigna L
    Quad Sclavo Diagn; 1972 Mar; 8(1):208-15. PubMed ID: 4268408
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuroendocrinology in depression and schizophrenia (author's transl)].
    Langer G
    Arzneimittelforschung; 1978; 28(8):1280-1. PubMed ID: 582389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive inhibition and psychopathology: toward a less simplistic conceptualization].
    Everett J; Lajeunesse C
    Encephale; 2000; 26(2):13-20. PubMed ID: 10858910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.
    Solomon PR; Crider A; Winkelman JW; Turi A; Kamer RM; Kaplan LJ
    Biol Psychiatry; 1981 Jun; 16(6):519-37. PubMed ID: 7196265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indolealkylamines and behavior.
    Airaksinen MM; McIsaac WM
    Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospects for research on schizophrenia. VI. Biochemical hypotheses and new techniques.
    Matthysse S; Smith EL; Puck TT; Edelman GM
    Neurosci Res Program Bull; 1972 Nov; 10(4):446-55. PubMed ID: 4663825
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alcoholism and depression (author's transl)].
    Cottereau MJ; Tanios A; Chamballon O
    Encephale; 1980; 6(3):209-26. PubMed ID: 7004854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain bio-amines and schizophrenia: a summary of research findings and implications for nursing.
    Rickelman B
    J Psychiatr Nurs Ment Health Serv; 1979 Sep; 17(9):28-36. PubMed ID: 225489
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
    Bunney WE
    Adv Biochem Psychopharmacol; 1977; 16():635-7. PubMed ID: 883562
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of amitriptyline on the metabolism of catecholamines and serotonin in depressed patients].
    Bruno A; Cumer Bruno S
    Riv Neurobiol; 1969; 15(4):749-61. PubMed ID: 5403687
    [No Abstract]   [Full Text] [Related]  

  • 36. Proposal for a noradrenaline hypothesis of schizophrenia.
    Yamamoto K; Hornykiewicz O
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):913-22. PubMed ID: 15363614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic abnormalities in postmortem schizophrenic brain.
    Mackay AV; Bird ED; Iversen LL; Spokes EG; Creese I; Snyder SH
    Adv Biochem Psychopharmacol; 1980; 24():325-33. PubMed ID: 7405668
    [No Abstract]   [Full Text] [Related]  

  • 39. Sources of contribution to the understanding of the etiology of mood disorders.
    Lipton MA; Prange AJ; Wilson IC
    Proc Annu Meet Am Psychopathol Assoc; 1972; 60():117-31. PubMed ID: 4621831
    [No Abstract]   [Full Text] [Related]  

  • 40. Postmortem studies in psychiatry.
    Bracha HS; Kleinman JE
    Psychiatr Clin North Am; 1984 Sep; 7(3):473-85. PubMed ID: 6384958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.